Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Knecht

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
HIV Medicine|March 8, 2014
Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV CohortA Reitter, A U Stücker, R Linde, et al.
Medical Microbiology and Immunology|August 24, 2014
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysisT Wolf, B Fuß, P Khaykin, et al.
HIV Medicine|July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 yearsI Krznaric, M Bickel, A Carganico, et al.
European Journal of Medical Research|October 19, 2010
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patientsC Stephan, H Jaeger, A Carganico, et al.
HIV Medicine|September 22, 2012
End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 yearsM Bickel, W Marben, C Betz, et al.
HIV Medicine|March 4, 2014
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearanceP Ingiliz, I Krznaric, H-J Stellbrink, et al.
Der Nervenarzt|August 5, 2017
[Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN]J L Müller, N Saimeh, P Briken, et al.
HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.
European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
HIV Medicine|March 8, 2014
Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV CohortA Reitter, A U Stücker, R Linde, et al.
Medical Microbiology and Immunology|August 24, 2014
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysisT Wolf, B Fuß, P Khaykin, et al.
HIV Medicine|July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 yearsI Krznaric, M Bickel, A Carganico, et al.
European Journal of Medical Research|October 19, 2010
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patientsC Stephan, H Jaeger, A Carganico, et al.
HIV Medicine|September 22, 2012
End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 yearsM Bickel, W Marben, C Betz, et al.
HIV Medicine|March 4, 2014
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearanceP Ingiliz, I Krznaric, H-J Stellbrink, et al.
Der Nervenarzt|August 5, 2017
[Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN]J L Müller, N Saimeh, P Briken, et al.
HIV Medicine|May 12, 2016
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisG Fätkenheuer, H Jessen, A Stoehr, et al.
European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.
Pageof 3